Mary L. McMaster

7.1k total citations · 3 hit papers
57 papers, 4.0k citations indexed

About

Mary L. McMaster is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Mary L. McMaster has authored 57 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 26 papers in Pathology and Forensic Medicine and 17 papers in Molecular Biology. Recurrent topics in Mary L. McMaster's work include Chronic Lymphocytic Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Mary L. McMaster is often cited by papers focused on Chronic Lymphocytic Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). Mary L. McMaster collaborates with scholars based in United States, Sweden and United Kingdom. Mary L. McMaster's co-authors include Alisa M. Goldstein, Dilys M. Parry, Naoko Ishibe, Christina M. Bromley, Margaret A. Tucker, Porcia T. Bradford, Lynn R. Goldin, Ola Landgren, Steven P. Treon and Meletios Α. Dimopoulos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Mary L. McMaster

53 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chordoma: incidence and survival patterns in the United States, 1973–1995

2001 708 citations Mary L. McMaster, Alisa M. Goldstein et al. profile →
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

2003 621 citations Mary L. McMaster et al. Seminars in Oncology profile →
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

2005 560 citations Lois B. Travis, Sophie D. Fosså et al. JNCI Journal of the National Cancer Institute profile →

Peers

Mary L. McMaster

GENET

PFM

RHEUM

PRM

ONCOL

Christine Beham‐Schmid Austria

Fabio Menestrina Italy

Véronique Minard‐Colin France

Jo‐Anne Vergilio United States

David M. Menke United States

Michele Bisceglia Italy

Jóhannes Björnsson United States

Akihiko Yoshida Japan

Ewa Kościelniak Germany

Ryo Ichinohasama Japan

Christine Beham‐Schmid Austria

Mary L. McMaster

555 ×0.4

GENET

754 ×0.6

PFM

441 ×0.5

RHEUM

223 ×0.3

PRM

640 ×0.8

ONCOL

Citations per year, relative to Mary L. McMaster Mary L. McMaster (= 1×) peers Christine Beham‐Schmid

Countries citing papers authored by Mary L. McMaster

Since Specialization

Citations

This map shows the geographic impact of Mary L. McMaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary L. McMaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary L. McMaster more than expected).

Fields of papers citing papers by Mary L. McMaster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary L. McMaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary L. McMaster. The network helps show where Mary L. McMaster may publish in the future.

Co-authorship network of co-authors of Mary L. McMaster

This figure shows the co-authorship network connecting the top 25 collaborators of Mary L. McMaster. A scholar is included among the top collaborators of Mary L. McMaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary L. McMaster. Mary L. McMaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pemov, Alexander, Jung Kim, Wen Luo, et al.. (2024). The landscape of rare genetic variants in familial Waldenström macroglobulinemia. PubMed. 1(2). 100013–100013. 2 indexed citations

Koka, Hela, Weiyin Zhou, Mary L. McMaster, et al.. (2024). Genomic profiles and clinical presentation of chordoma. Acta Neuropathologica Communications. 12(1). 129–129. 2 indexed citations

McMaster, Mary L.. (2023). The epidemiology of Waldenström macroglobulinemia. Seminars in Hematology. 60(2). 65–72. 12 indexed citations

Zhou, Weiyin, Lynn R. Goldin, Mingyi Wang, et al.. (2018). Combined somatic mutation and copy number analysis in the survival of familial CLL. British Journal of Haematology. 181(5). 604–613.

McMaster, Mary L.. (2018). Familial Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. 32(5). 787–809. 5 indexed citations

Rotunno, Melissa, Mary L. McMaster, Joseph F. Boland, et al.. (2016). Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene. Haematologica. 101(7). 853–860. 22 indexed citations

Pathak, Anand, Katja Seipel, Alexander Pemov, et al.. (2015). Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family. Haematologica. 101(7). 846–852. 33 indexed citations

Pathak, Anand, Alexander Pemov, Mary L. McMaster, et al.. (2015). Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family. Human Genetics. 134(7). 775–787. 18 indexed citations

Vajdic, Claire M., Ola Landgren, Mary L. McMaster, et al.. (2014). Medical History, Lifestyle, Family History, and Occupational Risk Factors for Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia: The InterLymph Non-Hodgkin Lymphoma Subtypes Project. JNCI Monographs. 2014(48). 87–97. 22 indexed citations

10.

Kaplan, Lee M., Rosemary Foster, Yiping Shen, et al.. (2010). Monozygotic twins discordant for neurofibromatosis 1. American Journal of Medical Genetics Part A. 152A(3). 601–606. 28 indexed citations

11.

McMaster, Mary L., Sigurður Y. Kristinsson, Ingemar Turesson, Magnus Björkholm, & Ola Landgren. (2009). Novel Aspects Pertaining to the Relationship of Waldenström's Macroglobulinemia, IgM Monoclonal Gammopathy of Undetermined Significance, Polyclonal Gammopathy, and Hypoglobulinemia. Clinical Lymphoma & Myeloma. 9(1). 19–22. 24 indexed citations

12.

Kristinsson, Sigurður Y., Jill Koshiol, Lynn R. Goldin, et al.. (2009). Genetics- and Immune-Related Factors in the Pathogenesis of Lymphoplasmacytic Lymphoma/Waldenström's Macroglobulinemia. Clinical Lymphoma & Myeloma. 9(1). 23–26. 7 indexed citations

13.

Liang, Xueying, Neil E. Caporaso, Mary L. McMaster, et al.. (2009). Common genetic variants in candidate genes and risk of familial lymphoid malignancies. British Journal of Haematology. 146(4). 418–423. 34 indexed citations

14.

Koshiol, Jill, Gloria Gridley, Eric A. Engels, Mary L. McMaster, & Ola Landgren. (2008). Chronic Immune Stimulation and Subsequent Waldenström Macroglobulinemia. Archives of Internal Medicine. 168(17). 1903–1903. 34 indexed citations

15.

Lindor, Noralane M., et al.. (2008). Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition. JNCI Monographs. 2008(38). 3–93. 191 indexed citations

16.

McMaster, Mary L., Lynn R. Goldin, Yan Bai, et al.. (2006). Genomewide Linkage Screen for Waldenström Macroglobulinemia Susceptibility Loci in High-Risk Families. The American Journal of Human Genetics. 79(4). 695–701. 48 indexed citations

17.

Travis, Lois B., Sophie D. Fosså, Sara J. Schonfeld, et al.. (2005). Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors. JNCI Journal of the National Cancer Institute. 97(18). 1354–1365. 560 indexed citations breakdown →

18.

Fosså, Sophie D., Jinbo Chen, Sara J. Schonfeld, et al.. (2005). Risk of Contralateral Testicular Cancer: A Population-based Study of 29 515 U.S. Men. JNCI Journal of the National Cancer Institute. 97(14). 1056–1066. 150 indexed citations

19.

McMaster, Mary L.. (2003). Familial Waldenstrom's macroglobulinemia. Seminars in Oncology. 30(2). 146–152. 51 indexed citations

20.

Greco, F. Anthony, J P Greer, David H. Johnson, et al.. (1993). Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.. Journal of Clinical Oncology. 11(5). 943–949. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact